THE METABOLISM AND KINETICS OF DOXAZOSIN IN MAN, MOUSE, RAT AND DOG

被引：74

作者：

KAYE, B

CUSSANS, NJ

FAULKNER, JK

STOPHER, DA

REID, JL

机构：

[1] PFIZER LTD,CENT RES,DEPT CLIN RES,SANDWICH CT13 9NJ,KENT,ENGLAND

[2] STOBHILL GEN HOSP,DEPT MATERIA MEDICA,GLASGOW G21 3UW,SCOTLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 21卷

关键词：

D O I：

10.1111/j.1365-2125.1986.tb02849.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S19 / S25

页数：7

共 10 条

[1] THE ALPHA-1-ADRENOCEPTOR ANTAGONIST PROFILE OF DOXAZOSIN - PRECLINICAL PHARMACOLOGY
ALABASTER, VA
DAVEY, MJ
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 : S9 - S17
[2] PRAZOSIN, PHARMACOKINETICS AND CONCENTRATION EFFECT
BATEMAN, DN
HOBBS, DC
TWOMEY, TM
STEVENS, EA
RAWLINS, MD
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 177 - 181
[3] DUTTON GJ, 1966, GLUCURONIC ACID FREE, P116
[4] A PHARMACODYNAMIC AND PHARMACOKINETIC ASSESSMENT OF A NEW ALPHA-ADRENOCEPTOR ANTAGONIST, DOXAZOSIN (UK33274) IN NORMOTENSIVE SUBJECTS
ELLIOTT, HL
MEREDITH, PA
SUMNER, DJ
MCLEAN, K
REID, JL
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (05) : 699 - 703
[5] A LONG-TERM DOUBLE-BLIND COMPARISON OF DOXAZOSIN AND ATENOLOL IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION
FRICK, MH
HALTTUNEN, P
HIMANEN, P
HUTTUNEN, M
PORSTI, P
PITKAJARVI, T
POYHONEN, L
PYYKONEN, ML
REINIKAINEN, P
SALMELA, P
SARASTE, M
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 : S55 - S62
[6] HEPATIC VASCULAR BED
GREENWAY, CV
STARK, RD
[J]. PHYSIOLOGICAL REVIEWS, 1971, 51 (01) : 23 - +
[7] SINGLETON W, 1980, WORLD C CLIN PHARM T
[8] METABOLIC-FATE OF PRAZOSIN
TAYLOR, JA
TWOMEY, TM
VONWITTENAU, MS
[J]. XENOBIOTICA, 1977, 7 (06) : 357 - 364
[9] TIMMERMANS PBMWM, 1980, ARCH INT PHARMACOD T, V245, P218
[10] DOXAZOSIN, AN ALPHA-1-ADRENOCEPTOR ANTAGONIST - PHARMACOKINETICS AND CONCENTRATION-EFFECT RELATIONSHIPS IN MAN
VINCENT, J
ELLIOTT, HL
MEREDITH, PA
REID, JL
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (06) : 719 - 725

← 1 →